Literature DB >> 22890814

Nitric oxide inhibits the accumulation of CD4+CD44hiTbet+CD69lo T cells in mycobacterial infection.

John E Pearl1, Egidio Torrado, Michael Tighe, Jeffrey J Fountain, Alejandra Solache, Tara Strutt, Susan Swain, Rui Appelberg, Andrea M Cooper.   

Abstract

Animals lacking the inducible nitric oxide synthase gene (nos2(-/-)) are less susceptible to Mycobacterium avium strain 25291 and lack nitric oxide-mediated immunomodulation of CD4(+) T cells. Here we show that the absence of nos2 results in increased accumulation of neutrophils and both CD4(+) and CD8(+) T cells within the M. avium containing granuloma. Examination of the T-cell phenotype in M. avium infected mice demonstrated that CD4(+)CD44(hi) effector T cells expressing the Th1 transcriptional regulator T-bet (T-bet(+)) were specifically reduced by the presence of nitric oxide. Importantly, the T-bet(+) effector population could be separated into CD69(hi) and CD69(lo) populations, with the CD69(lo) population only able to accumulate during chronic infection within infected nos2(-/-) mice. Transcriptomic comparison between CD4(+)CD44(hi)CD69(hi) and CD4(+)CD44(hi)CD69(lo) populations revealed that CD4(+)CD44(hi)CD69(lo) cells had higher expression of the integrin itgb1/itga4 (VLA-4, CD49d/CD29). Inhibition of Nos2 activity allowed increased accumulation of the CD4(+) CD44(hi)T-bet(+)CD69(lo) population in WT mice as well as increased expression of VLA-4. These data support the hypothesis that effector T cells in mycobacterial granulomata are not a uniform effector population but exist in distinct subsets with differential susceptibility to the regulatory effects of nitric oxide.
© 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22890814      PMCID: PMC3664054          DOI: 10.1002/eji.201142158

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  50 in total

1.  Effects of nitric oxide on the induction and differentiation of Th1 cells.

Authors:  W Niedbala; X Q Wei; D Piedrafita; D Xu; F Y Liew
Journal:  Eur J Immunol       Date:  1999-08       Impact factor: 5.532

2.  T cell costimulation via the integrin VLA-4 inhibits the actin-dependent centralization of signaling microclusters containing the adaptor SLP-76.

Authors:  Ken Nguyen; Nicholas R Sylvain; Stephen C Bunnell
Journal:  Immunity       Date:  2008-06       Impact factor: 31.745

3.  Regulation of granuloma fibrosis by nitric oxide during Mycobacterium avium experimental infection.

Authors:  Susana Lousada; Manuela Flórido; Rui Appelberg
Journal:  Int J Exp Pathol       Date:  2006-08       Impact factor: 1.925

4.  Identification of nitric oxide synthase as a protective locus against tuberculosis.

Authors:  J D MacMicking; R J North; R LaCourse; J S Mudgett; S K Shah; C F Nathan
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-13       Impact factor: 11.205

Review 5.  Inducible nitric oxide synthase: what difference does it make?

Authors:  C Nathan
Journal:  J Clin Invest       Date:  1997-11-15       Impact factor: 14.808

Review 6.  Nitric oxide: orchestrating hypoxia regulation through mitochondrial respiration and the endoplasmic reticulum stress response.

Authors:  Weiming Xu; Ian G Charles; Salvador Moncada
Journal:  Cell Res       Date:  2005-01       Impact factor: 25.617

7.  IL-4 inhibits VLA-4 expression on Tc1 cells resulting in poor tumor infiltration and reduced therapy benefit.

Authors:  Kotaro Sasaki; Angela D Pardee; Hideho Okada; Walter J Storkus
Journal:  Eur J Immunol       Date:  2008-10       Impact factor: 5.532

8.  Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction.

Authors:  J A Corbett; R G Tilton; K Chang; K S Hasan; Y Ido; J L Wang; M A Sweetland; J R Lancaster; J R Williamson; M L McDaniel
Journal:  Diabetes       Date:  1992-04       Impact factor: 9.461

Review 9.  Peroxynitrite: biochemistry, pathophysiology and development of therapeutics.

Authors:  Csaba Szabó; Harry Ischiropoulos; Rafael Radi
Journal:  Nat Rev Drug Discov       Date:  2007-08       Impact factor: 84.694

10.  IFN-gamma acts directly on activated CD4+ T cells during mycobacterial infection to promote apoptosis by inducing components of the intracellular apoptosis machinery and by inducing extracellular proapoptotic signals.

Authors:  Xujian Li; K Kai McKinstry; Susan L Swain; Dyana K Dalton
Journal:  J Immunol       Date:  2007-07-15       Impact factor: 5.422

View more
  12 in total

Review 1.  Mouse model of tuberculosis.

Authors:  Andrea M Cooper
Journal:  Cold Spring Harb Perspect Med       Date:  2014-09-25       Impact factor: 6.915

Review 2.  Orchestration of pulmonary T cell immunity during Mycobacterium tuberculosis infection: immunity interruptus.

Authors:  Samuel M Behar; Stephen M Carpenter; Matthew G Booty; Daniel L Barber; Pushpa Jayaraman
Journal:  Semin Immunol       Date:  2014-10-11       Impact factor: 11.130

Review 3.  Understanding and overcoming the barriers to T cell-mediated immunity against tuberculosis.

Authors:  Kevin B Urdahl
Journal:  Semin Immunol       Date:  2014-10-28       Impact factor: 11.130

4.  Tuberculosis, pulmonary cavitation, and matrix metalloproteinases.

Authors:  Catherine W M Ong; Paul T Elkington; Jon S Friedland
Journal:  Am J Respir Crit Care Med       Date:  2014-07-01       Impact factor: 21.405

Review 5.  The balance between protective and pathogenic immune responses in the TB-infected lung.

Authors:  Ian M Orme; Richard T Robinson; Andrea M Cooper
Journal:  Nat Immunol       Date:  2015-01       Impact factor: 25.606

Review 6.  Manipulation of BCG vaccine: a double-edged sword.

Authors:  V K Singh; R Srivastava; B S Srivastava
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-01-25       Impact factor: 3.267

7.  Nitric oxide and Brazilian propolis combined accelerates tissue repair by modulating cell migration, cytokine production and collagen deposition in experimental leishmaniasis.

Authors:  Milena Menegazzo Miranda; Carolina Panis; Allan Henrique Depieri Cataneo; Suelen Santos da Silva; Natalia Yoshie Kawakami; Luiz Gonzaga de França Lopes; Alexandre Tadachi Morey; Lucy Megumi Yamauchi; Célia Guadalupe Tardelli de Jesus Andrade; Rubens Cecchini; Jean Jerley Nogueira da Silva; José Maurício Sforcin; Ivete Conchon-Costa; Wander Rogério Pavanelli
Journal:  PLoS One       Date:  2015-05-14       Impact factor: 3.240

Review 8.  Location, location, location: the impact of migratory heterogeneity on T cell function.

Authors:  Bas J G Baaten; Andrea M Cooper; Susan L Swain; Linda M Bradley
Journal:  Front Immunol       Date:  2013-10-08       Impact factor: 7.561

9.  A new recombinant BCG vaccine induces specific Th17 and Th1 effector cells with higher protective efficacy against tuberculosis.

Authors:  Adeliane Castro da Costa; Abadio de Oliveira Costa-Júnior; Fábio Muniz de Oliveira; Sarah Veloso Nogueira; Joseane Damaceno Rosa; Danilo Pires Resende; André Kipnis; Ana Paula Junqueira-Kipnis
Journal:  PLoS One       Date:  2014-11-14       Impact factor: 3.240

10.  Interleukin 27R regulates CD4+ T cell phenotype and impacts protective immunity during Mycobacterium tuberculosis infection.

Authors:  Egidio Torrado; Jeffrey J Fountain; Mingfeng Liao; Michael Tighe; William W Reiley; Rachel P Lai; Graeme Meintjes; John E Pearl; Xinchun Chen; Daniel E Zak; Ethan G Thompson; Alan Aderem; Nico Ghilardi; Alejandra Solache; K Kai McKinstry; Tara M Strutt; Robert J Wilkinson; Susan L Swain; Andrea M Cooper
Journal:  J Exp Med       Date:  2015-08-17       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.